Healthcare

The European healthcare market is undergoing transformational change. Our thematic investment approach is centred on specialist care, where post-deregulation growth drivers include ageing populations, treatment innovation, and digitalization.

Palamon has a track record as one of the most successful investors in the highly fragmented European outpatient specialist care market with a value creation strategy majoring on platform consolidation. We have created undisputed local leaders in ophthalmology through Ober Scharrer Gruppe in Germany, acute elderly care centers through SARquavitae in Spain and dentistry through {my}dentist in the UK. Leveraging our buy-and-build strategies we have completed more than 100 healthcare platform acquisitions to date.

“Palamon’s strategic insight was significant in the early stages and throughout the roll-out of our expansion plans. We have really enjoyed our close relationship with the Palamon team and this has been an essential factor in the company’s success.”“We selected Palamon as a partner that shared our vision for regional growth and a dedication to the excellent patient service we provide. Palamon have surpassed expectations as a strategic partner, financial supporter and investment manager.”“Palamon has been a highly supportive partner and we are delighted with the success of this investment for our company.”

— Bradley Gould, CEO, Prospitalia— Dr Armin Scharrer, Co-Founder, OberSharrer Grupe (now Veonet)— Antoni Soler Vicens, SARQuavitae

Healthcare Investments

Item 1 of 5

Healthcare News